Peroxisome proliferators and peroxisome proliferator-activated receptor α: Biotic and xenobiotic sensing

American Journal of Pathology

Volumn 164, Issue 6, 2004, Pages 2305-2321

  Reddy, Janardan K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; FIBRIC ACID DERIVATIVE; NAFENOPIN; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PIRINIXIC ACID; XENOBIOTIC AGENT;

CONFERENCE PAPER; DNA DAMAGE; DRUG STRUCTURE; HUMAN; LIPID METABOLISM; LIVER CARCINOGENESIS; LIVER TOXICITY; MALIGNANT TRANSFORMATION; NONHUMAN; OXIDATIVE STRESS; PEROXISOME; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

EID: 2442635417     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63787-X     Document Type: Conference Paper

References (156)

1. Hess R, Staubli W, Riess W: Nature of the hepatomegalic effect of produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature 1965, 208:856-858
2. Svoboda D, Azarnoff DL: Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB). J Cell Biol 1966, 30:442-450
3. Svoboda D, Azarnoff D, Reddy J: Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands. J Cell Biol 1969, 40:734-746
4. Reddy J, Bunyaratvej S, Svoboda D: Microbodies in experimentally altered cells. IV. Acatalasemic (CSb) mice treated with CPIB. J Cell Biol 1969, 42:587-596
5. Reddy J, Chiga M, Bunyaratvej S, Svoboda D: Microbodies in experimentally altered cells. VII. CPIB-induced hepatic microbody proliferation in the absence of significant catalase synthesis. J Cell Biol 1970, 44:226-234
6. Reddy JK: Possible properties of microbodies (peroxisomes): microbody proliferation and hypolipidemic drugs. J Histochem Cytochem 1973, 21:967-971
7. Reddy JK, Azarnoff DL, Svoboda DJ, Prasad JD: Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice: absence of sex difference in response. J Cell Biol 1974, 61:344-358
8. Reddy JK: Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB. Am J Pathol 1974, 75:103-118
9. Reddy JK, Krishnakantha TP: Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science 1975, 190:787-789
10. Lazarow PB, De Duve C: A fatty acyl-CoA oxidizing system in rat liver peroxisomes: enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 1976, 73:2043-2046
11. Reddy JK, Rao MS, Moody DE: Hepatocellular carcinoma in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res 1976, 36:1211-1217
12. Reddy JK, Rao MS: Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator. J Natl Cancer Inst 1977, 59:1645-1650
13. Reddy JK, Rao MS, Azarnoff DL, Sell S: Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2, 3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in rat and mouse liver. Cancer Res 1979, 39:152-161
14. Reddy JK, Qureshi SA: Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-α-p chlorophenoxyisobutyrate (clofibrate) in rats. Br J Cancer 1979, 40:476-482
15. Reddy JK, Azarnoff DL, Hignite CE: Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 1980, 283:397-398
16. Warren JR, Simmon VF, Reddy JK: Properties of hypolipidemic peroxisome proliferators in the lymphocyte (3H)thymidine and Salmonella mutagenesis assays. Cancer Res 1980, 40:36-41
17. Reddy JK, Lalwani ND: Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit Rev Toxicol 1983, 12:1-58
18. Reddy JK, Rao MS: Peroxisome proliferators and cancer: mechanisms and implications. Trends Pharmacol Sci 1986, 7:438-443
19. Rao MS, Reddy JK: Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis 1987, 8:631-636
20. Reddy JK, Lalwani ND, Reddy MK, Qureshi SA: Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators. Cancer Res 1982, 42:259-266
21. Rao MS, Lalwani ND, Watanabe TK, Reddy JK: Inhibitory effect of antioxidants ethoxyquin and (2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator. Cancer Res 1984, 44:1072-1076
22. Fahl WE, Lalwani ND, Watanabe T, Goel SK, Reddy JK: DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes. Proc Natl Acad Sci USA 1984, 81:7827-7830
23. Goel SK, Lalwani ND, Reddy JK: Peroxisome proliferation and lipid peroxidation in rat liver. Cancer Res 1986, 46:1324-1331
24. Reddy JK, Goel SK, Nemali MR, Carrino JJ, Laffler TG, Reddy MK, Sperbeck SJ, Osumi T, Hashimoto T, Lalwani ND, Rao MS: Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc Natl Acad Sci USA 1986, 83:1747-1751
25. Reddy JK: Carcinogenicity of peroxisome proliferators: evaluation and mechanisms. Biochem Soc Trans 1990, 18:92-94
26. Issemann I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990, 347:645-650
27. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W: Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992, 68:879-887
28. Rhodin J: Correlation of ultrastructural organization and function in normal and experimentally changed proximal convoluted tubule cells of the mouse kidney. Aktiebolaget Godvil, Stockholm, 1954
29. De Duve C: Functions of microbodies (peroxisomes). J Cell Biol 1965, 27:25A-26A
30. De Duve C: The peroxisome in retrospect. Ann NY Acad Sci 1996, 804:1-10
31. Rouiller C, Bernhard W: "Microbodies" and the problem of mitochondrial regeneration in liver cells. J Biophys Biochem Cytol Suppl 1956, 2:355-359
32. De Duve C, Baudhuin P: Peroxisomes (microbodies and related particles). Physiol Rev 1966, 46:323-357
33. Muller M, Hogg JF, De Duve C: Distribution of tricarboxylic acid cycle enzymes and glyoxylate cycle enzymes between mitochondria and peroxisomes in Tetrahymena pyriformis. J Biol Chem 1968, 243:5385-5395
34. Novikoff AB, Goldfischer S: Visualization of peroxisomes (microbodies) and mitochondria with diaminobenzidine. J Histochem Cytochem 1969, 17:675-680
35. Hruban Z, Vigil EL, Slesers A, Hopkins E: Microbodies: constituent organelles of animal cells. Lab Invest 1972, 27:184-191
36. Reddy J, Svoboda D: Microsomes (peroxisomes) in the interstitial cells of rodent testis. Lab Invest 1972, 26:657-665
37. Reddy J, Svoboda D: Microbodies in Leydig cell tumors of rat testis. J Histochem Cytochem 1972, 20:793-804
38. Bendayan M, Reddy JK: Immunocytochemical localization of catalase and heat-labile enoyl-CoA hydratase in the livers of normal and peroxisome proliferator-treated rats. Lab Invest 1982, 47:364-369
39. von den Bosch H, Schutgens RB, Wanders RJ, Tager JM: Biochemistry of peroxisomes. Annu Rev Biochem 1992, 61:157-197
40. Usuda N, Reddy MK, Hashimoto T, Rao MS, Reddy JK: Tissue specificity and species differences in the distribution of urate oxidase in peroxisomes. Lab Invest 1988, 58:100-111
41. Reddy PG, Nemali MR, Reddy MK, Reddy MN, Yuan PM, Yuen S, Laffler TG, Shiroza T, Kuramitsu HK, Usuda N, Chisholm RL, Rao MS, Reddy JK: Isolation and sequence determination of a cDNA clone for rat peroxisomal urate oxidase: liver-specific expression in the rat. Proc Natl Acad Sci USA 1988, 85:9081-9085
42. Alvares K, Widrow RJ, Abu-Jawdeh GM, Schmidt JV, Yeldandi AV, Rao MS, Reddy J: Rat urate oxidase produced by recombinant baculovirus expression; formation of peroxisome crystalloid core-like structures. Proc Natl Acad Sci USA 1992, 89:4908-4912
43. Yeldandi AV, Chu R, Reddy SK, Pan J, Usuda N, Lin Y, Rao MS, Reddy JK: Functional expression and peroxisomal targeting of rat urate oxidase in monkey kidney cells. Gene Express 1995, 5:125-132
44. Yeldandi AV, Yeldandi V, Kumar S, Murthy CV, Wang XD, Alvares K, Rao MS, Reddy JK: Molecular evolution of the urate oxidase-encoding gene in hominoid primates: nonsense mutations. Gene 1991, 109:281-284
45. Wu XW, Lee CC, Muzny DM, Caskey CT: Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci USA 1989, 86:9412-9416
46. Reddy JK, Hashimoto T: Peroxisomal β-oxidation and peroxisome proliferator-activated receptor α: an adaptive metabolic system. Ann Rev Nutr 2001, 21:193-230
47. Azarnoff DL, Reddy JK, Hignite C, Fitzgerald T: Structure activity relationship of clofibrate-like compounds on lipid metabolism. Proc 6th Int Congr Pharmacol 1975, 4:137-147
48. Moody DE, Reddy JK: Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds. Toxic Appl Pharamcol 1978, 45:497-504
49. Lalwani ND, Reddy MK, Qureshi SA, Sirtori CR, Abiko Y, Reddy JK: Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in rat liver. Hum Toxicol 1983, 2:27-48
50. Reddy JK, Chu R: Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon. Peroxisomes: Biology and Role in Toxicology and Disease. Edited by Reddy JK, Suga T, Mannaerts G, Lazarow P, Subramani S. Ann NY Acad Sci 1996, 804:176-201
51. Moody DE, Rao MS, Reddy JK: Mitogenic effect in mouse liver induced by a hypolipidemic drug, nafenopin. Virchows Arch B Cell Pathol 1977, 23:291-296
52. Moody DE, Reddy JK: Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator, SaH 42-348. J Cell Biol 1976, 71:768-780
53. Watanabe T, Lalwani ND, Reddy JK: Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate. Biochem J 1985, 227:767-775
54. Chu R, Lim H, Brumfield L, Liu H, Herring C, Ulintz P, Reddy JK, Davison M: Protein profiling of mouse livers with peroxisome proliferator-activated receptor α activation. Mol Cell Biol 2004, in press
55. Nemali MR, Usuda N, Reddy MK, Oyasu K, Hashimoto T, Osumi T, Rao MS, Reddy JK: Comparison of constitutive and inducible levels of expression of peroxisomal β-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res 1988, 48:5316-5324
56. Ashby J, Brady A, Elcombe CR, Elliott BM, Ishmael J, Odum J, Tugwood JD, Kettle S, Purchase IF: Mechanistically based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Human Exp Toxicol 1994, 13(Suppl 2):S1-117
57. Kluwe WM, McConnell EE, Huff JE, Haseman JK, Douglas JF, Hartwell WV: Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute. Environ Health Perspect 1982, 45:129-133
58. David RM, Moore MR, Cifone MA, Finney DC, Guest D: Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol Sci 1999, 50:195-205
59. Weisburger JH, Williams GM: The distinction between genotoxic and epigenetic carcinogens and implication for cancer risk. Toxicol Sci 2000, 57:4-5
60. Glauert HP, Reddy JK, Kennan WS, Sattler GL, Rao VS, Pitot HC: Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella. Cancer Lett 1984, 24:147-156
61. Schiestl RH, Reddy JK: Effect of peroxisome proliferators on intrachromosomal and interchromosomal recombination in yeast. Carcinogenesis 1990, 11:173-176
62. 32p-post-labeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro. Carcinogenesis 1985, 6:933-936
63. 32p post-labeling. Mutat Res 1991, 247:65-76
64. Rao MS, Lalwani ND, Scarpelli DG, Reddy JK: The absence of γ-glutamyltranspeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14, 643. Carcinogenesis 1982, 3:1231-1233
65. Rao MS, Reddy JK: Hepatocarcinogenesis of peroxisome proliferators. Ann NY Acad Sci 1996, 804:573-587
66. Meyer K, Lee J-S, Dyck PA, Cao WQ, Rao MS, Thorgeirsson SS, Reddy JK: Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis 2003, 24:975-984
67. Yeldandi AV, Rao MS, Reddy JK: Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat Res 2000, 448:159-177
68. Giometti CS, Liang X, Tollaksen SL, Wall DB, Lubman DM, Subbarao V, Rao MS: Mouse liver selenium binding protein decreased in abundance by peroxisome proliferators. Electrophoresis 2000, 21:2162-2169
69. Kasai H, Okada Y, Nishimura S, Rao MS, Reddy JK: Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res 1989, 49:2603-2605
70. Rusyn I, Asakura S, Pachkowski B, Bradford BU, Denissenko MF, Peters JM, Holland SM, Reddy JK, Cunningham ML, Swenberg JA: Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res 2004, 64:1050-1057
71. Yeldandi AV, Milano M, Subbarao V, Reddy JK, Rao MS: Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Cancer Lett 1989, 47:21-27
72. Overturf K, al-Dhalimy M, Ou CN, Finegold M, Grompe M: Serial transplantation reveals the stem-cell like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997, 151:1273-1280
73. 2-generating peroxisomal fatty acyl-CoA oxidase. Proc Natl Acad Sci USA 1995, 92:7080-7084
74. 2-generating peroxisomal fatty acyl-CoA oxidase. Int J Cancer 1997, 70:716-721
75. Dadras SS, Thorgeirsson SS, Rao MS, Reddy JK: Implication of hydrogen peroxide generation and apoptosis in the neoplastic transformation of mouse fibroblasts overexpressing peroxisomal fatty acyl-CoA oxidase. Int J Oncol 1998, 12:37-44
76. 2-generating peroxisomal urate oxidase. Cancer Res 1996, 56:4846-4852
77. Varanasi U, Chu R, Huang Q, Castellon R, Yeldandi AV, Reddy JK: Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene. J Biol Chem 1996, 271:2147-2155, 273:30842
78. Woodyatt NJ, Lambe KG, Myers KA, Tugwood JD, Roberts RA: The peroxisome proliferator (PP) response element upstream of the human acyl-CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs. Carcinogenesis 1999, 20:369-372
79. Lambe KG, Woodyatt NJ, Macdonald N, Chevalier S, Roberts RA: Species differences in sequence and activity of the peroxisome proliferator response element (PPRE) within the acyl CoA oxidase gene promoter. Toxicol Lett 1999, 100:119-127
80. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD: Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999, 401:79-82
81. Reddy JK, Jirtle RL, Watanabe TK, Reddy MK, Michalopoulos G, Qureshi SA: Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators. Cancer Res 1984, 44:2582-2589
82. Rao MS, Thorgeirsson S, Reddy MK, Lalwani ND, Evarts RE, Usman MI, Singh B, Reddy JK: Induction of peroxisome proliferation in hepatocytes transplanted into the anterior chamber of the eye: a model system for the evaluation of xenobiotic-induced effects. Am J Pathol 1986, 124:519-527
83. Rao MS, Reddy JK: Liver stem cells in pancreas. Disease Progression and Carcinogenesis in the Gastrointestinal Tract-Falk Symposium 132. Edited by Galle PR, Gerken G, Schmidt WE, Widenmann B. United Kingdom, Kluwer, 2003, pp 11-30
84. Lalwani ND, Fahl WE, Reddy JK: Detection of a nafenopin binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds. Biochem Biophys Res Commun 1983, 116:388-393
85. Lalwani ND, Alvares K, Reddy MK, Reddy MN, Parikh I, Reddy JK: Peroxisome proliferator binding protein: identification and partial characterization of nafenopin-, clofibric acid-, and ciprofibrate binding proteins from rat liver. Proc Natl Acad Sci USA 1987, 84:5142-5146
86. Reddy JK, Rao MS: Peroxisome proliferation-related oxidative stress and hepatocarcinogenesis. In: Carcinogenesis and Radiation Protection. Edited by Cerutti PA, Nygaard AF, Simic MG. New York, Plenum Press, 1987, pp 85-91
87. Surapureddi S, Yu S, Bu H, Hashimoto T, Yeldandi AV, Kashireddy P, Cherkaoui-Malki M, Qi C, Zhu YJ, Rao MS, Reddy JK: Identification of a transcriptionally active peroxisome proliferator-activated receptor α-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator. Proc Natl Acad Sci USA 2002, 99:11836-11841
88. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ: Nuclear receptors and lipid physiology: opening the X-files. Science 2001, 294:1866-1870
89. Zhu Y, Alvares K, Huang Q, Rao MS, Reddy JK: Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J Biol Chem 1993, 268:26817-26820
90. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM: mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994, 8:1224-1234
91. Willson TM, Brown PJ, Sternbach DD, Henke BR: The PPARS: from orphan receptors to drug discovery. J Med Chem 2000, 43:527-550
92. Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999, 20:649-688
93. Zhu Y, Qi C, Korenberg JR, Chen X-N, Noya D, Rao MS, Reddy JK: Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 1995, 92:7921-7925
94. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM: Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 1992, 358:771-774.
95. Gottlicher M, Widmark E, Li Q, Gustafsson JA: Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 1992, 89:4653-4657
96. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ: Targeted disruption of the α isoform of the peroxisome proliferators-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995, 15:3012-3022
97. Peters JM, Cattley RC, Gonzalez FJ: Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14, 643. Carcinogenesis 1997, 18:2029-2033
98. Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, Everett C, Reitman ML, Hudson LD, Gonzalez FJ: Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β/δ. Mol Cell Biol 2000, 20:5119-5128
99. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM: Peroxisome proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell 2003, 113:159-170
100. Hashimoto T, Fujita T, Usuda N, Cook W, Qi C, Peters JM, Gonzalez FJ, Yeldandi AV, Rao MS, Reddy JK: Peroxisomal and mitochondrial fatty acid β-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor α and peroxisomal fatty acyl-CoA oxidase: genotype correlation with fatty liver phenotype. J Biol Chem 1999, 274:19228-19236
101. Mueller E, Drori S, Aiyer A, Yie J, Sarraf P, Chen H, Hauser S, Rosen ED, Ge K, Roeder RG, Spiegelman BM: Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor γ isoforms. J Biol Chem 2002, 277:41925-41930
102. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, Rao MS, Gonzalez FJ, Reddy JK: Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator activated-receptor γ1 (PPARγ1) overexpression. J Biol Chem 2003, 278:498-505
103. Varanasi U, Chu R, Chu S, Espinosa R, LeBeau MM, Reddy JK: Isolation of the human peroxisomal acyl-CoA oxidase gene: organization, promoter analysis, and chromosomal localization. Proc Natl Acad Sci USA 1994, 91:3107-3111
104. Yu S, Rao MS, Reddy JK: Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis, and hepatocarcinogenesis. Curr Mol Med 2003, 3:561-572
105. Chu R, Lin Y, Rao MS, Reddy JK: Cooperative formation of higher order peroxisome proliferator-activated receptor and retinoid X receptor complexes on the peroxisome proliferator responsive element of the rat hydratase-dehydrogenase gene. J Biol Chem 1995, 50:29636-29639
106. Jia Y, Qi C, Zhang Z, Hashimoto T, Rao MS, Huyghe S, Suzuki Y, Van Veldhoven PP, Baes M, Reddy JK: Overexpression of peroxisome proliferator-activated receptor-α (PPARα)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal β-oxidation system. J Biol Chem 2003, 278:47232-47239
107. Cherkaoui-Malki M, Meyer K, Cao W-Q, Latruffe N, Yeldandi AV, Rao MS, Bradfield CA, Reddy JK: Identification of novel peroxisome proliferator-activated receptor α (PPARα) target genes in mouse liver using cDNA microarray analysis. Gene Express 2001, 9:291-304
108. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ: Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J Biol Chem 1998, 273:5678-5684
109. Wanders RJ, Vreken P, Ferdinandusse S, Jansen GA, Waterham HR, Van Roermund CWT, Van Grunsven EG: Peroxisomal fatty acid α- and β-oxidation in humans: enzymology, peroxisomal metabolite transporters, and peroxisomal diseases. Biochem Soc Trans 2001, 29:250-267
110. Fan C-Y, Pan J, Chu R, Lee D, Kluckman KD, Usuda N, Singh I, Yeldandi AV, Rao MS, Maeda N, Reddy JK: Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J Biol Chem 1996, 271:24698-24710
111. Qi C, Zhu Y, Pan J, Usuda N, Maeda N, Yeldandi AV, Rao MS, Hashimoto T, Reddy JK: Absence of spontaneous peroxisome proliferation in enoyl-CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver: further support for the role of fatty acyl-CoA oxidase in PPARα ligand metabolism. J Biol Chem 1999, 274:15775-15780
112. Fan C-Y, Pan J, Usuda N, Yeldandi AV, Rao MS, Reddy JK: Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase: implications for peroxisome proliferators activated receptor α natural ligand metabolism. J Biol Chem 1998, 273:15639-15645
113. Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS: Defect in peroxisome proliferator-activated receptor α inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 2000, 275:28918-28928
114. Glass CK, Rosenfeld MG: The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000, 14:121-141
115. McKenna NJ, O'Malley BW: Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108:465-474
116. Lewis BA, Reinberg D: The mediator coactivator complex: functional and physical roles in transcriptional regulation. J Cell Sci 2003, 116:3667-3675
117. Onate SA, Tsai SY, Tsai MJ, O'Malley BW: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995, 270:1354-1357
118. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG: A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996, 85:403-415
119. Zhu Y, Qi C, Calandra C, Rao MS, Reddy JK: Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor γ. Gene Express 1996, 6:185-195
120. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H: TIF2, a 160 kDa transcriptional mediator for the ligand dependent activation function AF-2 of nuclear receptors. EMBO J 1996, 15:3667-3675
121. Hong H, Kohli K, Garabedian MJ, Stallcup MR: GRIP1, a transcriptional coactivator for the AF-2 transctivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 1997, 17:2735-2744
122. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG: The transcriptional co-activator p/CIP binds CBP and mediates nuclear receptor function. Nature 1997, 387:677-684
123. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS: AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997, 277:965-968
124. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM: Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 1997, 90:569-580
125. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman FM: A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839
126. Zhu Y, Qi C, Jain S, Rao MS, Reddy JK: Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J Biol Chem 1997, 272:25500-25506
127. Zhu Y, Kan L, Qi C, Kanwar YS, Yeldandi AV, Rao MS, Reddy Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR. J Biol Chem 2000, 275:13510-13516
128. Heery DM, Kalkhoven E, Hoare S, Parker MG: A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997, 387:733-736
129. Yuan CX, Ito M, Fondell JD, Fu ZY, Roeder RG: The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc Natl Acad Sci USA 1998, 95:7939-7944
130. Zhu Y, Qi C, Jain S, Le Beau MM, Espinosa III R, Atkins GB, Lazar MA, Yeldandi AV, Rao MS, Reddy JK: Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer. Proc Natl Acad Sci USA 1999, 96:10848-10853
131. Misra P, Owuor ED, Li W, Yu S, Qi C, Meyer K, Zhu YJ, Rao MS, Kong AN, Reddy JK: Phosphorylation of transcriptional coactivator peroxisome proliferators-activated receptor (PPAR) binding protein (PBP): stimulation of transcriptional regulation by mitogen-activated protein kinase. J Biol Chem 2002, 277:48745-48754
132. Lee SK, Anzick SL, Choi JE, Bubendorf L, Guan XY, Jung YR, Kallioniemi OP, Kononen J, Trent JM, Azorsa D, Jhun BH, Cheong JH, Lee YC, Meltzer PS, Lee JW: A nuclear factor, ASC-2, is a cancer-amplified transcriptional coactivators essential for ligand-dependent transactivation by nuclear receptors in vivo. J Biol Chem 1999, 274:34283-34293
133. Mahajan MA, Samuels HH: A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB binding protein. Mol Cell Biol 2000, 20:5048-5063
134. Caira F, Antonson P, Pelto-Huikko M, Treuter E, Gustafsson JA: Cloning and characterization of RAP250, a novel nuclear receptor coactivators. J Biol Chem 2000, 275:5308-5317
135. Ko L, Cardona GR, Chin WW: Thyroid hormone receptor binding protein an LXXLL motif-containing protein, functions as a general coactivator. Proc Natl Acad Sci USA 2000, 97:6212-6217
136. Zhu Y, Qi C, Cao W-Q, Yeldandi AV, Rao MS, Reddy JK: Cloning and characterization of PIMT, a protein with methyltransferase domain, which interacts with and enhances nuclear receptor coactivator PRIP function. Proc Natl Acad Sci USA 2001, 98:10380-10385
137. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Naar AM, Erdjument-Bromage H, Tempst P, Freedman LP: Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999, 398:824-828
138. Ryu S, Zhou S, Ladurner AG, Tjian R: The transcriptional cofactor complex CRSP is required for activity of the enhancer binding protein Spl. Nature 1999, 397:446-450
139. Misra P, Qi C, Yu S, Shah SH, Cao W-Q, Rao MS, Thimmapaya B, Zhu Y, Reddy JK: Interaction of PIMT with transcription coactivators CBP, p300, and PBP differential role in transcriptional regulation. J Biol Chem 2002, 277:20011-20019
140. Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW, Stallcup MR: Regulation of transcription by a protein methyltransferase. Science 1999, 284:2174-2177
141. Mouaikel J, Verheggen C, Bertrand E, Tazi J, Bordonne R: Hypermethylation of the cap structure of both yeast snRNAs and snoRNAs requires a conserved methyltransferase that is localized to the nucleolus. Molec Cell 2002, 9:891-901
142. Enunlu I, Papai G, Cserpan I, Udvardy A, Jeang KT, Boros I: Different isoforms of PRIP-interacting protein with methyltransferase domain/trimethylguanosine synthase localizes to the cytoplasm and nucleus. Biochem Biophys Res Commun 2003, 309:44-51
143. Xu J, Qiü Y, DeMayo FJ, Tsai SY, Tsai MJ, O'Malley BW: Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 1998, 279:1922-1925
144. Qi C, Zhu Y, Pan J, Yeldandi AV, Rao MS, Maeda N, Subbarao V, Pulikuri S, Hashimoto T, Reddy JK: Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor α- regulated gene expression. Proc Natl Acad Sci USA 1999, 96:1585-1590
145. Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, O'Malley BW: The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci USA 2000, 97:6379-6384
146. Wang Z, Rose DW, Hermanson O, Liu F, Herman T, Wu W, Szeto D, Gleiberman A, Krones A, Pratt K, Rosenfeld R, Glass CK, Rosenfeld MG: Regulation of somatic growth by the p160 coactivator p/CIP. Proc Natl Acad Sci USA 2000, 97:13549-13554
147. Ge'hin M, Mark M, Dennefeld C, Dierich A, Gronemeyer H, Chambon C: The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol Cell Biol 2002, 22:5923-5937
148. Zhu Y, Qi C, Jia Y, Nye JS, Rao MS, Reddy JK: Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor binding protein, results in embryonic lethality. J Biol Chem 2000, 275:14779-14782
149. Ito M, Yuan CX, Okano HJ, Darnell RB, Roeder RG: Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. Molec Cell 2000, 5:683-693
150. Crawford SE, Qi C, Misra P, Stellmach V, Rao MS, Engel JD, Zhu Y, Reddy JK: Defects of the heart, eye, and megakaryocytes, in peroxisome proliferator activator receptor binding protein (PBP) null embryos implicate GATA family of transcription factors. J Biol Chem 2001, 277:3585-3592
151. Landles C, Chalk S, Steel JH, Rosewell I, Spencer-Dene B, Lalani EN, Parker MG: The thyroid hormone receptor-associated protein TRAP220 is required at distinct embryonic stages in placental, cardiac, and hepatic development. Mol Endocri 2003, 17:2418-1435
152. Zhu YJ, Crawford SE, Stellmach V, Dwivedi RS, Rao MS, Gonzalez FJ, Qi C, Reddy JK: Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. J Biol Chem 2003, 278:1986-1990
153. Kuang SQ, Liao L, Zhang H, Pereira FA, Yuan Y, DeMayo FJ, Ko L, Xu J: Deletion of the cancer amplified coactivator AIB3 results in defective placentation and embryonic lethality. J Biol Chem 2002, 277:45356-45360
154. Antonson P, Schuster GU, Wang L, Rozell B, Holter E, Flodby P, Treuter E, Holmgren L, Gustafsson JA: Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction. Mol Cell Biol 2003, 23:1260-1268
155. Qi C, Surapureddi S, Zhu YJ, Yu S, Kashireddy P, Rao MS, Reddy JK: Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor γ (PPARγ)-interacting protein, is required for PPARγ-mediated adipogenesis. J Biol Chem 2003, 278:25281-25284
156. Jia Y, Qi C, Kashireddy P, Surapureddi S, Zhu Y-J, Rao MS, Le Roith D, Chambon P, Gonzalez FJ, Reddy JK: Transcription coactivators PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARα-regulated gene expression in liver. J Biol Chem 2004, in press